馥感啉口服液治疗小儿毛细支气管炎58例

Efficacy of Fuganlin oral liquid for the treatment of 58 cases of children with capillary bronchitis

目的 :观察馥感啉口服液治疗小儿毛细支气管炎的疗效。方法 :选取毛细支气管炎患儿112例随机分为观察组58例和对照组54例。所有患者给予抗病毒、抗感染、雾化平喘等治疗,观察组在此基础上加用馥感啉口服液治疗,比较两组疗效。结果:观察组咳嗽消失、喘憋缓解、肺部湿啰音消失、肺部哮鸣音消失的时间均短于对照组(P<0.05),治疗有效率高于对照组(P<0.05)。两组患儿在治疗期间均无明显不良反应发生。结论 :馥感啉口服液治疗小儿毛细支气管炎疗效显著,安全性好。

Objective： To observe the efficacy of Fuganlin oral liquid for the treatment of children with capillary bronchitis. Methods： One hundred and twelve cases of pediatric patients were randomly divided into an observation group （n=58） and a control group （n=54）. All the patients were given anti-virus, anti-infection, atomizing asthma treatment, and meanwhile, the observation group was additionally given Fuganlin oral liquid treatment. The curative effects were compared between the two groups. Results： The time for the disappearance of the cough and the moist rale and wheezing sound of the lung and the asthma suppression mitigation was shorter in the observation group than in the control group （P〈0.05）. The treatment effective rate of the observation group was higher than that of the control group （P〈0.05）. There were no obvious adverse reactions in two groups during the treatment. Conclusion： Fuganlin oral liquid has obvious efficacy on children capillary bronchitis with good safety.